NPI: 1184694036 · SUMRALL, MS 39482 · Federally Qualified Health Center (FQHC) · NPI assigned 01/24/2006
Authorized official ROBINSON, JANICE controls 20+ related entities in our dataset. Read more
| Authorized Official | ROBINSON, JANICE (CHIEF EXECUTIVE OFFICER) |
| Parent Organization | SOUTHEAST MISSISSIPPI RURAL HEALTH INITIATIVE, INC |
| NPI Enumeration Date | 01/24/2006 |
Other providers sharing the same authorized official: ROBINSON, JANICE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,741 | $107K |
| 2019 | 5,285 | $235K |
| 2020 | 3,799 | $193K |
| 2021 | 5,089 | $189K |
| 2022 | 6,408 | $146K |
| 2023 | 6,857 | $123K |
| 2024 | 5,121 | $74K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10,113 | 8,928 | $936K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 576 | 469 | $77K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 4,508 | 3,731 | $43K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 39 | 30 | $5K |
| 36415 | Collection of venous blood by venipuncture | 2,341 | 2,159 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 208 | 177 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 563 | 436 | $792.41 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16 | 16 | $353.42 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 45 | 43 | $320.16 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 158 | 117 | $309.26 |
| 81003 | 430 | 386 | $104.07 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 176 | 157 | $5.76 |
| 83036 | Hemoglobin; glycosylated (A1C) | 81 | 72 | $1.94 |
| 3077F | 408 | 357 | $0.00 | |
| 1160F | 1,744 | 1,530 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 997 | 841 | $0.00 |
| 1159F | 1,743 | 1,531 | $0.00 | |
| 3078F | 1,966 | 1,785 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 728 | 619 | $0.00 |
| 80061 | Lipid panel | 80 | 69 | $0.00 |
| 82947 | 113 | 105 | $0.00 | |
| 90734 | 16 | 12 | $0.00 | |
| 81002 | 46 | 40 | $0.00 | |
| 99173 | 100 | 79 | $0.00 | |
| 81025 | 59 | 48 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 18 | 13 | $0.00 |
| 3008F | 3,180 | 2,807 | $0.00 | |
| 90686 | 316 | 275 | $0.00 | |
| 3079F | 635 | 581 | $0.00 | |
| Q2039 | Influenza virus vaccine, not otherwise specified | 68 | 67 | $0.00 |
| 36416 | 1,070 | 972 | $0.00 | |
| 3074F | 2,003 | 1,821 | $0.00 | |
| 1220F | 450 | 399 | $0.00 | |
| 3075F | 79 | 66 | $0.00 | |
| 85018 | 93 | 77 | $0.00 | |
| 92551 | 67 | 52 | $0.00 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 19 | 19 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 14 | 14 | $0.00 |
| 3080F | 34 | 26 | $0.00 |